<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.896874</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Paeonol Interferes With Quorum-Sensing in <italic>Pseudomonas aeruginosa</italic> and Modulates Inflammatory Responses <italic>In&#xa0;Vitro</italic> and <italic>In Vivo</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Huaqiao</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/849357"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Dan</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Ling</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1509879"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Fei</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/998652"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ye</surname>
<given-names>Gang</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1670544"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guo</surname>
<given-names>Hongrui</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1262581"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Huidan</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1399267"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Ling</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xu</surname>
<given-names>Zhiwen</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1541584"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Yinglun</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/617591"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>College of Veterinary Medicine, Sichuan Agricultural University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Chenhe Su, Wistar Institute, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Yiping Wang, University of Florida, United States; Lianci Peng, Southwest University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Zhiwen Xu, <email xlink:href="mailto:abtcxzw@126.com">abtcxzw@126.com</email>; Yinglun Li, <email xlink:href="mailto:liyinglun02@163.com">liyinglun02@163.com</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>896874</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Tang, Yang, Zhu, Shi, Ye, Guo, Deng, Zhao, Xu and Li</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Tang, Yang, Zhu, Shi, Ye, Guo, Deng, Zhao, Xu and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Developing quorum-sensing (QS) based anti-infection drugs is one of the most powerful strategies to combat multidrug-resistant bacteria. Paeonol has been proven to attenuate the QS-controlled virulence factors of <italic>P. aeruginosa</italic> by down-regulating the transcription of QS signal molecules. This research aimed to assess the anti-virulence activity and mechanism of paeonol against <italic>P. aeruginosa</italic> infection <italic>in vitro</italic> and <italic>in vivo</italic>. In this study, paeonol was found to reduce the adhesion and invasion of <italic>P.aeruginosa</italic> to macrophages and resist the cytotoxicity induced by <italic>P.aeruginosa</italic>. Paeonol reduced the expression of virulence factors of <italic>P.aeruginosa</italic> by inhibiting QS, thereby reducing the LDH release and damage of <italic>P.aeruginosa</italic>-infected macrophages. Paeonol can inhibit bacterial virulence and enhance the ability of macrophages to clear <italic>P.aeruginosa</italic>. In addition, paeonol exerts anti-inflammatory activity by reducing the expression of inflammatory cytokines and increasing the production of anti-inflammatory cytokines. Paeonol treatment significantly inhibited the activation of TLR4/MyD88/NF-&#x3ba;B signaling pathway and decreased the inflammation response of <italic>P. aeruginosa</italic>-infected macrophages. Paeonol also significantly reduced the ability of <italic>P.aeruginosa</italic> to infect mice and reduced the inflammatory response. These data suggest that paeonol can inhibit the virulence of <italic>P.aeruginosa</italic> and decrease the inflammation response in <italic>P.aeruginosa</italic>-infected macrophages and mice, which can decrease the damage induced by <italic>P.aeruginosa</italic> infection and enhance the ability of macrophages to clear bacteria. This study supports the further development of new potential anti-infective drugs based on inhibition of QS and virulence factors.</p>
</abstract>
<kwd-group>
<kwd>paeonol</kwd>
<kwd>
<italic>P. aeruginosa</italic>
</kwd>
<kwd>RAW264.7</kwd>
<kwd>quorum sensing</kwd>
<kwd>inflammation</kwd>
</kwd-group>
<counts>
<fig-count count="13"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="57"/>
<page-count count="14"/>
<word-count count="5617"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>
<italic>Pseudomonas aeruginosa</italic> (<italic>P. aeruginosa</italic>) is a common gram-negative bacterial opportunistic pathogen that is related to the development of acute and chronic pulmonary infections in cystic fibrosis (CF), non-CF bronchiectasis, and chronic obstructive pulmonary disease with high morbidity and mortality (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>). Lung infections caused by <italic>P. aeruginosa</italic> are exacerbated by the intracellular invasion and persistence of the pathogen, especially in CF patients. Intracellular invasion is a favorable mechanism for pathogens to avoid host defense and antimicrobial therapy (<xref ref-type="bibr" rid="B4">4</xref>). The intrinsic ability for <italic>P. aeruginosa</italic> to invade and adhere to host cells of infection is ascribed to its impenetrable biofilm formation and an elaborate arsenal of virulence factors designed to damage the host membrane barrier and evade immune responses, coupled with its rapidly acquired antibiotic resistance (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>Quorum-sensing (QS) is a signaling mechanism by which cell-to-cell&#xa0;communication receives input from adjacent cells and coordinates collective behavior, enabling the bacteria to survive within the host, releasing a range of virulence factors, and developing biofilm (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). <italic>P. aeruginosa</italic> produces an armory of factors associated with intracellular communication and extracellular virulence, regulated by the quorum-sensing system of the diffusible signaling molecule (N-acyl L-homoserine lactone, AHLs) and determines the pathogenesis of bacteria (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Early colonization and dissemination of <italic>P. aeruginosa</italic> infection in host tissues is initiated by proteases and elastases, while pyocyanin interferes with various cellular functions such as chelated iron absorption, respiration, and enhances virulence expression (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Rhamnolipid promotes the surface movement of <italic>P. aeruginosa</italic> to form biofilms and participates in the diffusion of mature biofilms (<xref ref-type="bibr" rid="B13">13</xref>). <italic>P. aeruginosa</italic> produces different secondary metabolites and multiple virulence factors to modify host defense response, and macrophages play a crucial role in infections of patients with CF (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>The lung innate immune response plays an important role in clearing lung pathogens. During the initial stages of <italic>P. aeruginosa</italic> invasion, the secretion of cytokines and chemokines induces many neutrophils to migrate to the infected site. However, the overactivation of innate immune cells (alveolar macrophages or neutrophils) can produce various proinflammatory molecules, causing severe airway injury and damaged lung function (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). After specifically recognizing microbial ligands, Toll-like receptors (TLRs) recruit various binding molecules to activate inflammatory gene transcription, and immune responses (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). <italic>P. aeruginosa</italic>-induced activation of macrophages is majorly based on the recognition of pathogens by molecular pattern receptors, including TLRs, such as TLR2 and TLR4, and the mannose receptor, thus activating downstream nuclear factor kappa B (NF-&#x3ba;B) and mitogen-activated protein kinase (MAPK) signaling pathway increasing macrophages release of various cytokines and chemokines from response to <italic>P. aeruginosa</italic> infection (<xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>Natural products targeted specific genes that inhibit the growth or pathogenicity of bacteria and control extracellular virulence, such as EGCG, Curcumin, and Eugenol-Containing Essential Oils, which have been investigated as QS inhibitors (<xref ref-type="bibr" rid="B23">23</xref>&#x2013;<xref ref-type="bibr" rid="B25">25</xref>). Paeonol is a polyphenolic compound originally extracted from <italic>Paeonia lactiflora</italic>, <italic>Moutan cortex</italic>, and <italic>Cynanchum paniculatum</italic>, which has been used wildly due to various medicinal benefits as an analgesic, antipyretic, and anti-inflammatory agent in traditional Chinese medicine (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Previous studies have demonstrated that paeonol attenuates quorum-sensing, inhibits virulence factors, and biofilm formation (<xref ref-type="bibr" rid="B28">28</xref>). Paeonol has been well-documented for revealing potential anti-inflammatory activity in macrophages (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>), but the possible mechanism by regulating virulence and inflammation to reduce pathological damage upon pathogenic <italic>P. aeruginosa</italic> infection has not yet been fully studied <italic>in vitro</italic> and <italic>in vivo</italic>.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Bacterial Strains and Culture Conditions</title>
<p>
<italic>P. aeruginosa</italic> PAO1 (ATCC 15692) was stored in our laboratory. For all the experiments, PAO1 was grown in LB broth at 37&#xb0;C with shaking, collected by centrifugation (4,000 rpm for 5&#xa0;min), and diluted in the appropriate experimental medium.</p>
</sec>
<sec id="s2_2">
<title>Cell Culture</title>
<p>RAW264.7 cells were obtained from the Cell Bank of the Chinese Academic of Sciences (Shanghai, China) and cultured in DMEM medium (HyClone, Beijing, China) with 10% fetal bovine serum (FBS, TransGen Biotech, Beijing, China) and antibiotics (100 U/ml penicillin and 100 &#xb5;g/ml streptomycin) (Haimen, China). The cells incubated in a cell incubator at 37&#xb0;C with humidified air and 5% CO<sub>2</sub>.</p>
</sec>
<sec id="s2_3">
<title>Cell Viability</title>
<p>The viability of RAW264.7 macrophage cells was determined using the CCK8 assay. Briefly, RAW264.7 (1 &#xd7; 10<sup>5</sup> cells/mL) were suspended in complete cell culture media, and 150 &#x3bc;L of the cell suspension was cultured in 96-well plates for 24&#xa0;h. After treatment with paeonol, cell viability was evaluated using the Cell Counting Kit-8 (Sangon, Biotech, Shanghai, China).</p>
</sec>
<sec id="s2_4">
<title>
<italic>P. aeruginosa</italic> Infection of Macrophages</title>
<p>The <italic>P. aeruginosa</italic>-infected macrophages model used in this study was performed as described previously (<xref ref-type="bibr" rid="B31">31</xref>). RAW264.7 cells were seeded into 12-well tissue culture plates at a density of 5&#xd7;10<sup>5</sup> cells/well and then reached 80-90% confluence. <italic>P. aeruginosa</italic> were collected and suspended to 10<sup>8</sup> CFUs/mL in DMEM without antibiotics. RAW264.7 cells were incubated with&#xa0;<italic>P. aeruginosa</italic> at three multiplicity of infection (MOIs, 25, 50, or 100) in DMEM without antibiotics. After 2&#x2009;h or 4&#xa0;h of PAO1 infection, cells were washed with phosphate-buffered saline (PBS), then lysed with 0.5% Triton-X for 15&#xa0;min at 37 &#xb0;C. For invasion assay, extracellular bacteria were killed with 200 &#x3bc;g/mL gentamicin for 1&#xa0;h. The attachment and invasion levels were assessed by bacterial plate count.</p>
</sec>
<sec id="s2_5">
<title>Cell Treatment</title>
<p>At 80%&#x2013;90% confluence, cells were washed third with PBS, then subsequently incubated with <italic>P. aeruginosa</italic> of 100 (MOI) in antibiotic-free DMEM for 4&#xa0;h. Cells were divided into four groups: the first part involved the control group (RAW264.7 cells group) and the <italic>P. aeruginosa</italic> infection group (PAO1). On this basis, the second part was set up as three parallel groups, namely PAO1 (MOI = 100:1, infection for 4&#xa0;h) as cells model group, paeonol pretreatment (32 &#x3bc;g/mL, 64 &#x3bc;g/mL and 128 &#x3bc;g/mL, pretreatment for 3&#xa0;h) + PAO1 group and paeonol (32 &#x3bc;g/mL, 64 &#x3bc;g/mL and 128 &#x3bc;g/mL, treatment for 4&#xa0;h) + PAO1 treatment group. These concentrations were no bacteriostatic effect, and previous studies confirmed that the MIC of paeonol against <italic>P.aeruginosa</italic> was greater than 512 &#x3bc;g/ml.</p>
</sec>
<sec id="s2_6">
<title>Determine&#xa0;mRNA Expression Levels of QS-Related Virulence Genes of <italic>P. aeruginosa</italic> by qPCR</title>
<p>Total&#xa0;RNA&#xa0;was&#xa0;reverse-transcribed&#xa0;to&#xa0;cDNA, and qPCR was&#xa0;carried&#xa0;out by the instruction of commercial kit. <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> shows the primers used to amplify <italic>lasI/R, rhlI/R, pqsA/R, LasA, LasB, rhlA, rhlC, phzm, phzM, phzH, phzS</italic>, and <italic>rpoD</italic> (reference gene). qPCR data were analyzed to calculate the relative differences in mRNA expression using the 2<sup>-&#x25b3;&#x25b3;CT</sup> method.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>qPCR primers of <italic>P. aeruginosa</italic> for analysis of gene expression.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Genes</th>
<th valign="top" colspan="2" align="center">Primer sequences (5, -3, )</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<bold>
<italic>lasI</italic>
</bold>
</td>
<td valign="top" align="left">F: CGCACATCTGGGAACTCA</td>
<td valign="top" align="left">R: CGGCACGGATCATCATCT</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>lasR</italic>
</bold>
</td>
<td valign="top" align="left">F: CTGTGGATGCTCAAGGACTAC</td>
<td valign="top" align="left">R: AACTGGTCTTGCCGATGG</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>rhlI</italic>
</bold>
</td>
<td valign="top" align="left">F: GTAGCGGGTTTGCGGATG</td>
<td valign="top" align="left">R: CGGCATCAGGTCTTCATCG</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>rhlR</italic>
</bold>
</td>
<td valign="top" align="left">F: GCCAGCGTCTTGTTCGG</td>
<td valign="top" align="left">R: CGGTCTGCCTGAGCCATC</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>pqsA</italic>
</bold>
</td>
<td valign="top" align="left">F: GACCGGCTGTATTCGATTC</td>
<td valign="top" align="left">R: GCTGAACCAGGGAAAGAAC</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>pqsR</italic>
</bold>
</td>
<td valign="top" align="left">F: CTGATCTGCCGGTAATTGG</td>
<td valign="top" align="left">R: ATCGACGAGGAACTGAAGA</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>lasA</italic>
</bold>
</td>
<td valign="top" align="left">F: CTGTGGATGCTCAAGGACTAC</td>
<td valign="top" align="left">R: AACTGGTCTTGCCGATGG</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>lasB</italic>
</bold>
</td>
<td valign="top" align="left">F: AACCGTGCGTTCTACCTGTT</td>
<td valign="top" align="left">R: CGGTCCAGTAGTAGCGGTTG</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>rhlA</italic>
</bold>
</td>
<td valign="top" align="left">F: TGGCCGAACATTTCAACGT</td>
<td valign="top" align="left">R: GATTTCCACCTCGTCGTCCTT</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>rhlC</italic>
</bold>
</td>
<td valign="top" align="left">F: GCCATCCATCTCGACGGAC</td>
<td valign="top" align="left">R: CGCAGGCTGTATTCGGTG</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>phzM</italic>
</bold>
</td>
<td valign="top" align="left">F: ACGGCTGTGGCGGTTTA</td>
<td valign="top" align="left">R: CCGTGACCGTCGCATT</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>phzA</italic>
</bold>
</td>
<td valign="top" align="left">F: AACGGTCAGCGGTACAGGGAAC</td>
<td valign="top" align="left">R: AACGGTCAGCGGTACAGGGAAAC</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>phzH</italic>
</bold>
</td>
<td valign="top" align="left">F: GCTCATCGACAATGCCGAACT</td>
<td valign="top" align="left">R: GCGGATCTCGCCGAACATCAG</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>phzS</italic>
</bold>
</td>
<td valign="top" align="left">F: CCGAAGGCAAGTCGCTGGTGA</td>
<td valign="top" align="left">R: GGTCCCAGTCGGCGAAGAACG</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>rpoD</italic>
</bold>
</td>
<td valign="top" align="left">F: GGGCGAAGAAGGAAATGGTC</td>
<td valign="top" align="left">R: CAGGTGGCGTAGGTGGAGAA</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_7">
<title>Lactate Dehydrogenase Assay</title>
<p>The macrophages infected with P. aeruginosa (MOI=100:1) for 4&#xa0;h, then treated with Paeonol at the concentrations of 32 &#x3bc;g/mL, 64 &#x3bc;g/mL and 128 &#x3bc;g/mL. The culture supernatants were harvested and centrifuged at 12,000 g for 5&#xa0;min, and LDH activity was monitored by an LDH cytotoxicity assay kit (Jiancheng Biotech, Nanjing, China).</p>
</sec>
<sec id="s2_8">
<title>Live/Dead cell Assay</title>
<p>The effects of paeonol on the viability or cytotoxicity of macrophages cells were assayed using the Calcein-AM/PI Double Stain Kit (Solarbio, Beijing, China). In brief, RAW264.7 cells were exposed to <italic>P. aeruginosa</italic> in DMEM without antibiotics and treated with paeonol. The cells washed with PBS three times and stained with a 100 &#x3bc;L Calcein-AM/PI stain solution at 37&#xb0;C for 15&#xa0;min. Living cells with green cytoplasmic fluorescence and dead cells with red nuclei were immediately observed by the fluorescence microscope.</p>
</sec>
<sec id="s2_9">
<title>Adhesion and Invasion Assay</title>
<p>To further reveal the role of paeonol on macrophage-mediated phagocytosis, the intracellular killing of <italic>P. aeruginosa</italic>. Macrophages infected with <italic>P. aeruginosa</italic> (MOI=25:1 for 4&#xa0;h) treated with paeonol (32, 64, and 128 &#x3bc;g/mL). Cells were washed with phosphate-buffered saline (PBS) and then lysed with 0.5% Triton-X for 15&#xa0;min at 37&#xb0;C. Extracellular bacteria were killed with 200 &#x3bc;g/mL gentamicin for 1&#xa0;h to evaluate the intracellular bacteria. Attachment and invasion levels were assessed by bacterial plate count.</p>
</sec>
<sec id="s2_10">
<title>Ultrastructure Examination by Transmission Electron Microscope</title>
<p>The macrophages infected with <italic>P. aeruginosa</italic> (MOI=25:1 for 2&#xa0;h) were treated with Paeonol (128 &#x3bc;g/ml). The cells were washed with PBS three times, and fixed with 2.5% glutaraldehyde at 4&#xb0;C overnight. Samples were collected and treated with osmium ferrocyanide for 1&#xa0;h, dehydrated in graded ethanol concentrations (50%, 70%, 80%, 90%, 95%, and 100%) and 100% acetone, infiltrated, and embedded in epoxy resin. Subsequently, ultrathin sections (60-80&#xa0;nm) were cut with a diamond knife on a microtome (Leica EM UC7; Leica Corporation, Germany) and were stained with saturated aqueous uranyl acetate and counterstained with 4% lead citrate, and finally observed using HT-7700 TEM (Hitachi, Tokyo, Japan).</p>
</sec>
<sec id="s2_11">
<title>Flow Cytometry Assay</title>
<p>Paeonol (32 &#x3bc;g/mL, 64 &#x3bc;g/mL and 128 &#x3bc;g/mL) treated macrophages (infected with <italic>P. aeruginosa</italic> (MOI=25:1) for 2&#xa0;h) were washed with PBS, separated to single-cell suspension, and resuspended in staining buffer (BD Biosciences). The cells were stained with F4/80 (Elabscience, E-AB-F0995C), CD86 (Elabscience, E-AB-F0994E), and CD206 (Elabscience, E-AB-F1135D) fluorescently labeled antibody, then detected by a flow cytometer (Beckman coulter, CytoFLEX) and analyzed by the Flowjo software.</p>
</sec>
<sec id="s2_12">
<title>Determination of&#xa0;mRNA Expression Levels of Inflammation and TLR4/MyD88/NF-&#x3ba;B Pathway of Macrophages by qPCR</title>
<p>The mRNA expression levels of the TLR4/MyD88/NF-&#x3ba;B pathway of Paeonol treated RAW264.7 (infected with <italic>P. aeruginosa</italic> (MOI=100:1) for 4&#xa0;h) cells were assayed by qPCR. The gene sequences of TLR4, MyD88, TRAM, NF-&#x3ba;B, I&#x3ba;B, I&#x3ba;B&#x3b1;, IKK-&#x3b2;, p65, p50, TNF-&#x3b1;, IL-1&#x3b2;, IL-6, IL-8, iNOS, COX-2, IL-2, IL-4, and IL-10 were retrieved from NCBI, and the primers of these genes (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>) were synthesized by HuaDa Gene company (Beijing, China). GAPDH gene was selected as the reference gene. qPCR reaction was conducted on a LightCycler<sup>&#xae;</sup>II real-time fluorescent quantitative PCR instrument (Roche, USA) using the PerfectStartTM Green qPCR SuperMix (TransGen Biotech, Beijing, China) following the standard steps. All data output from the qPCR experiments were analyzed using the 2<sup>-&#x394;&#x394;CT</sup> method.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>List of primers of the macrophage TLR4/MyD88/NF-&#x3ba;B pathway in qPCR analysis.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Genes</th>
<th valign="top" colspan="2" align="center">Primer sequences (5, -3, )</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>TNF-&#x3b1;</italic>
</bold>
</td>
<td valign="top" align="left" style="background-color:#ffffff">F: CTTCTGTCTACTGAACTTCGGG</td>
<td valign="top" align="left" style="background-color:#ffffff">R: CAGGCTTGTCACTCGAATTTTG</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>IL-1&#x3b2;</italic>
</bold>
</td>
<td valign="top" align="left" style="background-color:#ffffff">F: GAAATGCCACCTTTTGACAG</td>
<td valign="top" align="left" style="background-color:#ffffff">R: TGGATGCTCTCATCAGGACAG</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>IL-6</italic>
</bold>
</td>
<td valign="top" align="left" style="background-color:#ffffff">F: CTTCCATCCAGTTGCCTTCT</td>
<td valign="top" align="left" style="background-color:#ffffff">R: CCTTCTGTGACTCCAGCTTATC</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>IL-8</italic>
</bold>
</td>
<td valign="top" align="left" style="background-color:#ffffff">F: TGTGGGAGGCTGTGTTTGTA</td>
<td valign="top" align="left" style="background-color:#ffffff">R: ACGAGACCAGGAGAAACAGG</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>IFN-&#x3b2;</italic>
</bold>
</td>
<td valign="top" align="left">F: CAGCTCCAAGAAAGGACGAAC</td>
<td valign="top" align="left">R: GGCAGTGTAACTCTTCTGCAT</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>iNOS</italic>
</bold>
</td>
<td valign="top" align="left">F: ACTGTGCCATCAGCAAGGTT</td>
<td valign="top" align="left">R: GCTCTTTGTCCATTGGGTTCTT</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>COX-2</italic>
</bold>
</td>
<td valign="top" align="left">F: TGCTGTACAAGCAGTGGCAA</td>
<td valign="top" align="left">R: GCAGCCATTTCCTTCTCTCC</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>IL-2</italic>
</bold>
</td>
<td valign="top" align="left">F: TGTGGAATGGCGTCTCTGTC</td>
<td valign="top" align="left">R: AGTTCAATGGGCAGGGTCTC</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>IL-4</italic>
</bold>
</td>
<td valign="top" align="left">F: GGTCTCAACCCCCAGCTAGT</td>
<td valign="top" align="left">R: GCCGATGATCTCTCTCAAGTGAT</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>IL-10</italic>
</bold>
</td>
<td valign="top" align="left" style="background-color:#ffffff">F: GCCGAGGAGATCGTCACC</td>
<td valign="top" align="left" style="background-color:#ffffff">R: CAGGCGTAGAAGATGTCGGA</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>TLR4</italic>
</bold>
</td>
<td valign="top" align="left">F: GGACTCTGATCATGGCACTG</td>
<td valign="top" align="left">R: CTGATCCATGCATTGGTAGGT</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>MyD88</italic>
</bold>
</td>
<td valign="top" align="left">F: ACTCGCAGTTTGTTGGATG</td>
<td valign="top" align="left">R: CACCTGTAAAGGCTTCTCG</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>TRAM</italic>
</bold>
</td>
<td valign="top" align="left">F: AGCCAGAAAGCAATAAGC</td>
<td valign="top" align="left">R: CAAACCCAAAGAACCAAG</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>NF-&#x3ba;B</italic>
</bold>
</td>
<td valign="top" align="left" style="background-color:#ffffff">F: CTGAAACTACTGATTGCTGCTGGA</td>
<td valign="top" align="left" style="background-color:#ffffff">R: GCTATGTGAAGAGGCGTTGTGC</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>I&#x3ba;B</italic>
</bold>
</td>
<td valign="top" align="left">F: GCCATCCCAGGCAGTATCTA</td>
<td valign="top" align="left">R: TTCCAAGACCAGACCTCCAG</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>I&#x3ba;B&#x3b1;</italic>
</bold>
</td>
<td valign="top" align="left">F: GCCCTTCTGGGATTTCCT</td>
<td valign="top" align="left">R: GCGGCTCCGCTTCGTTCT</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>IKK-&#x3b2;</italic>
</bold>
</td>
<td valign="top" align="left">F: TCAGCTAATGTCCCAGCCTTC</td>
<td valign="top" align="left">R: CCAGTCTAGAGTCGTGAAGC</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>P65</italic>
</bold>
</td>
<td valign="top" align="left">F: CGGGATGGCTACTATGAGGCTGACC</td>
<td valign="top" align="left">R: GATTCGCTGGCTAATGGCTTGCT</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>P50</italic>
</bold>
</td>
<td valign="top" align="left">F: GTGATTTGTGCCAGCCAGGAAGC</td>
<td valign="top" align="left">R: TTCTTAACCCGAAGCCCTTGATT</td>
</tr>
<tr>
<td valign="top" align="left" style="background-color:#ffffff">
<bold>
<italic>GAPDH</italic>
</bold>
</td>
<td valign="top" align="left" style="background-color:#ffffff">F: GGTGAAGGTCGGTGTGAACG</td>
<td valign="top" align="left" style="background-color:#ffffff">R: CTCGCTCCTGGAAGATGGTG</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_13">
<title>Anti-Infection Activity of Paeonol Against <italic>P. aeruginosa</italic> by Quorum Sensing <italic>In Vivo</italic>
</title>
<p>Fifty SPF mice (4 weeks) were obtained from Sibeifu Biotechnology Co. Ltd. (Beijing, China). The animals were housed at 22-25&#xb0;C on a 12&#xa0;h day-night cycle, fed standard rodent chow and sterile water ad libitum for 1 week of acclimation. All protocols for animal studies were reviewed and approved by the Animal Ethical Committee of Sichuan Agricultural University (#20210021). The mice were randomly divided into six groups (n=10): the control group, PAO 1 group, PAO 1+Pae (25 mg/kg) group, PAO 1+Pae (50 mg/kg), PAO 1+Pae (100 mg/kg), and CIP (20 mg/kg) group (positive control). The mice were administered the same dose of saline or drugs by intragastric administration for three days. In mice, infection was induced using the previously described method with modifications (<xref ref-type="bibr" rid="B32">32</xref>). Briefly, mice were weighed, anesthetized, and then received an intratracheal instillation of PAO 1 (2.5 &#xd7; 10<sup>8</sup> CFU) in 20 &#x3bc;l phosphate-buffered saline (PBS) to model the acute infection of PAO 1. The mice were anesthetized and sacrificed after 24&#xa0;h of infection, and lung tissue samples were harvested rapidly for subsequent analysis. Then the bacterial load, the expression of virulence, and inflammation cytokines were evaluated by PCR.</p>
</sec>
<sec id="s2_14">
<title>Statistical Analysis</title>
<p>All values are expressed as mean &#xb1; standard deviation (SD). All statistical analyses were performed using SPSS 20.0. Differences between all groups were analyzed using the one-way ANOVA test, and the result with <italic>P</italic> &lt; 0.05 or <italic>P</italic> &lt; 0.01 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>The Cytotoxicity Evaluation of Paeonol</title>
<p>The viability of RAW264.7 cells was performed in the presence of paeonol (0-512 &#xb5;g/mL) using the CCK-8 assay. The viability of cells is more than 90% at&#xa0;concentrations&#xa0;of&#xa0;0-128 &#xb5;g/mL of paeonol, indicating that paeonol was not cytotoxic to RAW264.7 cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The CCK8 assay was used to determine the cytotoxicity of paeonol on RAW264.7 cells. All data were expressed as means &#xb1; SD (n=3). **<italic>P</italic> &lt; 0.01 vs the control group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>The Model of Macrophages Infected With <italic>P. aeruginosa</italic>
</title>
<p>The prolonged <italic>P. aeruginosa</italic> infection has been shown to cause a significant decrease in cell viability, arrest of cell growth, and morphology alternation, ultimately weakening the host&#x2019;s innate immune system&#x2019;s defense function and impaired bacterial clearance function. RAW264.7 cells were infected with <italic>P. aeruginosa</italic> at different MOI (25, 50, 100) to explore the effect of <italic>P. aeruginosa</italic> infection on bacterial adhesion and invasion. <xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref> indicated that <italic>P. aeruginosa</italic> could adhere to and invade the cells. As the PAO1 MOI value and infection time increased, the number of&#xa0;<italic>P. aeruginosa</italic>&#xa0;attaching to and invading macrophages increased (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The adhesion <bold>(A)</bold> and invasion <bold>(B)</bold> of <italic>P. aeruginosa</italic> infected RAW264.7 cells with different MOI (10, 50, 100). The extracellular or intracellular bacteria were counted by plate. For the invasion assay, extracellular bacteria were killed with 200 &#x3bc;g/mL gentamicin. All data were expressed as means &#xb1; SD (n=3). *P &lt; 0.05, **<italic>P</italic> &lt; 0.01 vs the control group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Paeonol Attenuate QS Genes of <italic>P. aeruginosa</italic> in Macrophages Infection Model</title>
<p>
<italic>P. aeruginosa</italic> secretes various virulence factors and forms biofilms regulated by the QS system. QS-related genes, including <italic>lasI, lasR, rhlI, rhlR, pqsA</italic>, and <italic>pqsR</italic> were analyzed following pretreatment or treatment with paeonol. The results showed that paeonol downregulated the expression of QS-related virulence genes of PAO1, and the therapeutic effect is significantly greater than the preventive effect. The inhibition rate in the presence of paeonol (128 &#x3bc;g/ml) was as follows: <italic>lasI</italic> 58.95%, <italic>lasR</italic> 59.20%, <italic>rhlI</italic> 40.19%, <italic>rhlR</italic> 41.20<italic>%, pqsA</italic> 39.33%, <italic>pqsR</italic> 58.26%. These results demonstrated the anti-infection activity of paeonol against <italic>P. aeruginosa-</italic>infected macrophages by interfering with QS-mediated related genes expression in a concentration-dependent manner (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Transcriptional levels of the QS genes during <italic>P. aeruginosa</italic> infected macrophages (MOI = 100:1) following pretreatment and treatment with paeonol. lasI, rhlI, pqsA, lasR, rhlR, and pqsR. &#x201c;Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were pretreated with paeonol for 3&#xa0;h before infection with PAO1. &#x201c;PAO1+Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were infected with PAO1 and treated with paeonol at the same time. The expression of mRNA was tested by RT-PCR. All data were expressed as means &#xb1; SD (n=3). *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 vs the control group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Paeonol Attenuate Virulence Genes During <italic>P. aeruginosa</italic> Infected Macrophages</title>
<p>
<italic>P. aeruginosa</italic> secretes a variety of virulence factors and forms biofilms, the expression of QS-regulated and QS-virulence genes was detected to assess the anti-infection activity of paeonol against <italic>P. aeruginosa-</italic>infected macrophages. QS system was analyzed in the macrophages cell infected <italic>P. aeruginosa</italic> following pretreatment and treatment at the same time with paeonol. The results showed that paeonol downregulated the expression of QS-related virulence genes in PAO1 infected RAW264.7 macrophages, and the therapeutic effect is significantly greater than the preventive effect. The inhibition rate in the presence of paeonol (128 &#x3bc;g/ml) was as follows: <italic>lasA</italic> 56.47%, <italic>lasB</italic> 61.81%, <italic>rhlA</italic> 47.65%, <italic>rhlC</italic> 56.74%, <italic>phzA</italic> 18.28%, <italic>phzM</italic> 7.73%, <italic>phzH</italic> 45.50% and <italic>phzS</italic> 35.47% (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Transcriptional levels of the virulence genes during <italic>P. aeruginosa</italic> infected macrophages (MOI = 100:1) following pretreatment and treatment with paeonol. <bold>(A)</bold> lasA, <bold>(B)</bold> lasB, <bold>(C)</bold> rhlA, <bold>(D)</bold> rhlC <bold>(E)</bold> phzA, <bold>(F)</bold> phzH, <bold>(G)</bold> phzM, <bold>(H)</bold> phzS, &#x201c;Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were treated with paeonol for 3&#xa0;h before infection with PAO1. &#x201c;PAO1+Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were infected with PAO1 and treated with paeonol at the same time. The expression of mRNA was tested by RT-PCR. All data were expressed as means &#xb1; SD (n=3). *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 vs the control group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Viability and Cytotoxicity of Paeonol on Macrophages Infected With <italic>P. aeruginosa</italic>
</title>
<p>Bacterial infection can cause the destruction of the membrane structure of cells, resulting in the release of LDH in the cytoplasm into the culture medium. The detection of cytotoxicity can be achieved by detecting the activity of LDH in the culture medium. The LDH levels were detected by Fe<sup>2+</sup> - xylenol orange-based kit. Compared with the control (RAW264.7), PAO1 significantly inhibited the proliferation of macrophages cells, but the release of LDH decreased in a concentration-dependent manner by paeonol treatment, and paeonol did not affect the proliferation of macrophages at the experimental concentrations (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). To directly examine the cell viability or cytotoxicity, RAW264.7 cells were exposed to PAO1 treated without or with paeonol, then labeled with Calcein-AM and PI dyes and immediately observed by fluorescence microscope. <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref> illustrates that macrophages cells infected with PAO1 were mainly dead (red, propidium iodide-positive), but treated with paeonol groups were mainly viable cells (green, calcein-positive) and a few dead cells. The results indicated that paeonol within 128 &#x3bc;g/mL is not cytotoxic to RAW264.7 cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Cell viability were tested in PAO1 infected RAW264.7 (MOI = 25:1) without or with paeonol treatment for 4&#xa0;h. The Fe<sup>2+</sup> - xylenol orange-based LDH kit <bold>(A)</bold> and calcein-AM or PI dyes <bold>(B)</bold> were used in the testing. &#x201c;Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were pretreated with paeonol for 3&#xa0;h before infection with PAO1. &#x201c;PAO1+Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were infected with PAO1 and treated with paeonol. <sup>##</sup>p &lt; 0.01 vs.  Control Group, *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 vs the PAO1 group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g005.tif"/>
</fig>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Adhesion <bold>(A)</bold> and invasion <bold>(B)</bold> were tested in PAO1-infected RAW264.7 (MOI = 25:1) with paeonol treatment for 4 hours. &#x201c;PAO1+Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were infected with PAO1 and treated with paeonol. The bacteria were cultivated and counted on a TSB plate. All data were expressed as means &#xb1; SD (n=3). **<italic>P</italic> &lt; 0.01 vs the control group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g006.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>Paeonol Decreased the Adhesion and Invasion of PAO1</title>
<p>RAW264.7 cells were infected with PAO1 to determine the bacterial adhesion and invasion. Compared with the PAO1 group, bacteria adhesion on macrophages significantly decreased after paeonol treatment. Further study revealed that paeonol reduced the invasion of PAO1 to RAW264.7 cells (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>).</p>
</sec>
<sec id="s3_7">
<title>Effects of Paeonol on the Ultrastructure of RAW264.7 Macrophages Infected by PAO1</title>
<p>TEM was performed to detect the ultrastructure of RAW264.7 macrophages infected by PAO1 and treated with paeonol. As shown in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>, there were no significant changes in the blank control group. In the PAO1 group, <italic>P. aeruginosa</italic> invaded macrophages, PAO1 was encapsulated by vesicles, part of the vesicle membrane was destroyed, mitochondria were swollen and vacuolized, escaped phagosomes into the cytoplasm, causing nuclear shrinkage, and even cell damage or lysis. In the paeonol(128 &#x3bc;g/mL) treated group, <italic>P. aeruginosa</italic> invasion was reduced and encapsulated by intact vesicles, the mycelium changed from rod-like to round, the fusion between PAO1 and lysosome increased, the mitochondria slightly swollen and more filamentous, the nucleus of the cell was intact, and the cell injury was reduced.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Transmission electron microscope observation of paeonol on the ultrastructure of RAW264.7 macrophages infected with <italic>P. aeruginosa</italic> PAO1 (MOI=25:1). Scale bar, 2 &#x3bc;m (low magnification in columns one and three) and 1 &#x3bc;m (high magnification in columns two and four); red* indicates PAO1, blue* indicates mitochondria; red arrows indicate vesicles, blue arrows indicate autophagosome-lysosomes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g007.tif"/>
</fig>
</sec>
<sec id="s3_8">
<title>Paeonol Suppressed Inflammation in RAW264.7 Cells Infected <italic>P. aeruginosa</italic>
</title>
<p>Compared with the control group, the relative mRNA expression level of IL-1&#x3b2;, IL-6, IL-8, TNF-&#x3b1;, COX2, and iNOS in the PAO1 group was upregulated, respectively. Compared with the PAO1 group, paeonol can attenuate the expression of inflammatory cytokines like IL-1&#x3b2;, IL-6, IL-8, TNF-&#x3b1;, various inflammatory mediators such as COX2, iNOS, and upregulated the relative mRNA expression level of IL-2, IL-4, IL-10. Paeonol treatment significantly prevented the inflammation changes induced by <italic>P. aeruginosa</italic> in a dose-dependent manner (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Cytokines mRNA expression were tested in PAO1-infected RAW264.7 (MOI = 100:1) with paeonol treatment. <bold>(A)</bold> TNF-&#x3b1;, <bold>(B)</bold> IL-1&#x3b2;, <bold>(C)</bold> IL-6, <bold>(D)</bold> IL-8, <bold>(E)</bold> iNOS, <bold>(F)</bold> COX-2, <bold>(G)</bold> IL-2, <bold>(H)</bold> IL-4, <bold>(I)</bold> IL-10, &#x201c;PAO1+Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were infected with PAO1 and treated with paeonol. The expression of mRNA was tested by RT-PCR. All data were expressed as means &#xb1; SD (n=3). <sup>#</sup>p &lt; 0.05, <sup>##</sup>p &lt; 0.01 vs. control Group, *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 <italic>vs</italic> the PAO1 group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g008.tif"/>
</fig>
</sec>
<sec id="s3_9">
<title>Paeonol Changed the Polarization of Macrophages</title>
<p>Flow cytometry was used to detect macrophage polarization. F4/80 biomarker was used to label macrophages, and CD86/CD206 anti-body was used to check the surface biomarker of macrophages, respectively. The CD86 biomarker significantly was significantly upregulated when macrophages were infected with PAO1. Paeonol significantly decreased the polarization of macrophages by decreeing the CD86 biomarker when the treatment concentrations higher than 64 &#x3bc;g/mL (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9</bold>
</xref>).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Paeonol changed the Polarization of Macrophages infected with PAO1 (MOI = 25:1). Control <bold>(A)</bold>, PAO1 <bold>(B)</bold> The data in &#x201c;PAO1+Pae 32 &#x3bc;g/mL&#x201d; <bold>(D)</bold>, &#x201c;PAO1+Pae 64 &#x3bc;g/mL&#x201d; <bold>(E)</bold>, and &#x201c;PAO1+Pae 128 &#x3bc;g/mL&#x201d; <bold>(F)</bold> indicated that Paeonol reversed the upregulated the biomarker of CD86 of RAW264.7 cells infected with PAO1 <bold>(C)</bold>. The cell polarization was distinguished by Flow cytometry. All data were expressed as means &#xb1; SD (n=3). *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 <italic>vs</italic> PAO1 group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g009.tif"/>
</fig>
</sec>
<sec id="s3_10">
<title>Effect of Paeonol on the TLR4/MyD88/NF-&#x3ba;B Pathway of Macrophages Infected With <italic>P. aeruginosa</italic>
</title>
<p>TLR4/MyD88/NF-&#x3ba;B pathway is the fetal inflammation pathway for macrophages responding to the bacteria infection. To investigate the effect of paeonol on the TLR4/MyD88/NF-&#x3ba;B signaling pathway, the mRNA expression levels of TLR4, MyD88, TRAM, NF-&#x3ba;B, I&#x3ba;B, I&#x3ba;B&#x3b1;, IKK-&#x3b2;, p65, and p50 were measured by qPCR. In Paeonol treated cells, the mRNA expression levels of TLR4, MyD88, TRAM, NF-&#x3ba;B, I&#x3ba;B, I&#x3ba;B&#x3b1;, IKK-&#x3b2;, p65, and p50 were significantly downregulated, and I&#x3ba;B was markedly higher in comparison with those in the PAO1 group. These results demonstrated that paeonol attenuated <italic>P. aeruginosa</italic>-induced inflammation as evidenced by decreased expressions of TLR4/MyD88/NF-&#x3ba;B pathway in RAW264.7 cells, data were included in <xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref>.</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>Paeonol inhibited the activation of TLR4/MyD88/NF-&#x3ba;B pathway in PAO1 infected RAW264.7 (MOI = 100:1). RAW264.7 were exposed to PAO1 treated without or with paeonol for 4&#xa0;h to determine the mRNA expression levels of the TLR4/MyD88/NF-&#x3ba;B pathway. <bold>(A)</bold> TLR4, <bold>(B)</bold> MyD88, <bold>(C)</bold> TRAM, <bold>(D)</bold> NF-&#x3ba;B, <bold>(E)</bold> I&#x3ba;B, <bold>(F)</bold> I&#x3ba;B&#x3b1;, <bold>(G)</bold> IKK-&#x3b2;, <bold>(H)</bold> p65, <bold>(I)</bold> p50, &#x201c;PAO1+Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;PAO1+Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were infected with PAO1 and treated with paeonol. &#x201c;Pae 32 &#x3bc;g/mL&#x201d;, &#x201c;Pae 64 &#x3bc;g/mL&#x201d;, &#x201c;Pae 128 &#x3bc;g/mL&#x201d; indicate that RAW264.7 cells were treated with paeonol but without PAO1 infection. The expression of mRNA was tested by RT-PCR. All data were expressed as means &#xb1; SD (n=3). <sup>#</sup>p &lt; 0.05, <sup>##</sup>p &lt; 0.01 vs.  Control Group, *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 vs the PAO1 group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g010.tif"/>
</fig>
</sec>
<sec id="s3_11">
<title>Paeonol Showed an Effective Anti-Infection Activity <italic>In Vivo</italic>
</title>
<p>Paeonol decreased the PAO1 load in the lung and inhibited the mRNA expression of inflammation cytokines, including IL-1&#x3b2;, IL-6, and TNF-&#x3b1; (<xref ref-type="fig" rid="f11">
<bold>Figures&#xa0;11</bold>
</xref>, <xref ref-type="fig" rid="f12">
<bold>12</bold>
</xref>). The mRNA expression of IL-4 was increased by IL-4. All three concentrations of paeonol decreased the expression of quorum sensing-related genes, <italic>rhlR</italic>, <italic>LasR</italic>, and <italic>pqsA</italic> (<xref ref-type="fig" rid="f13">
<bold>Figure&#xa0;13</bold>
</xref>).</p>
<fig id="f11" position="float">
<label>Figure&#xa0;11</label>
<caption>
<p>Paeonol decreased the bacterial load in the lung. All data were expressed as means &#xb1; SD (n=3). *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 vs PAO1 group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g011.tif"/>
</fig>
<fig id="f12" position="float">
<label>Figure&#xa0;12</label>
<caption>
<p>Paeonol inhibited the mRNA expression of inflammation cytokines in the lung. All data were expressed as means &#xb1; SD (n=3). <bold>(A)</bold> IL-1&#x3b2;, <bold>(B)</bold> IL-2, <bold>(C)</bold> IL-4, <bold>(D)</bold> IL-6, <bold>(E)</bold>TNF-&#x3b1;. *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 vs PAO1 group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g012.tif"/>
</fig>
<fig id="f13" position="float">
<label>Figure&#xa0;13</label>
<caption>
<p>Paeonol inhibited the mRNA expression of QS genes in the lung. <bold>(A)</bold> lasI, <bold>(B)</bold> lasR, <bold>(C)</bold> rhlI, <bold>(D)</bold> rhlR, <bold>(E)</bold> pqsA. All data were expressed as means &#xb1; SD (n=3). *<italic>P</italic> &lt; 0.05 or **<italic>P</italic> &lt; 0.01 vs PAO1 group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896874-g013.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Due to the excessive and indiscriminate use of antibiotics, multidrug-resistant (MDR) bacteria are rapidly increasing and difficult to control by using conventional antibiotics (<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>). <italic>P. aeruginosa</italic>, a prevalent nosocomial-acquired and opportunistic pathogen, causes various acute and chronic infections, often involving the synergy of multiple virulence gene regulatory factors (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Macrophages are crucial innate immune cells that play a critical role in the host&#x2019;s response to bacterial infection. Macrophages pattern recognition receptors (PRRs), especially TLRs, recognize pathogen-associated molecular patterns (PAMPs) and activate intracellular various signaling pathways, such as inflammation, phagocytosis, apoptosis, and autophagy (<xref ref-type="bibr" rid="B38">38</xref>). Excessive inflammatory cytokines are detrimental to the host at the later stages of infection, and limiting excessive inflammatory response is crucial to controlling <italic>P. aeruginosa</italic> infection (<xref ref-type="bibr" rid="B39">39</xref>).</p>
<p>In the model of macrophages infected with <italic>P. aeruginosa</italic>, there was a significant up-regulation in the number of bacterial attachments and invasions to cells as the MOI value and infection time increased (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Therefore, the increase of co-aggregation between <italic>P. aeruginosa</italic> promotes the invasion of bacteria to macrophages, which may enable bacteria to evade host immune defense and cause great damage to host cells. The pathogenesis of <italic>P. aeruginosa</italic> is closely associated with biofilm formation, motility, and a myriad of extracellular virulence factors regulated by the QS system (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>). Large-scale expression of QS-related signaling molecules (AHL) or virulence factors (pyocyanin, protease, elastase, and rhamnolipids) were cytotoxic to macrophages (<xref ref-type="bibr" rid="B44">44</xref>). PAO1 significantly inhibited macrophages cell proliferation, induced cytotoxic responses, and led to cell membrane damage and rupture, lysis, and death. Our former studies had revealed that paeonol could attenuate quorum-sensing regulated virulence and biofilm formation in <italic>P. aeruginosa</italic> and show a protective effect on <italic>C. elegans</italic> infected with <italic>P. aeruginosa in vivo</italic> (<xref ref-type="bibr" rid="B28">28</xref>). Here, the potential therapeutic effect and mechanism of paeonol were investigated in a macrophage infected with a PAO1 cell model. The results revealed that paeonol inhibited <italic>P. aeruginosa</italic> QS-signaling pathway (lasI/R, rhlI/R, pqsA/pqsR) and virulence factors (<italic>lasA, lasB, rhlA, rhlC, phzA, phzM, phzH, and phzS</italic>) to alleviate the PAO1 induced cell damage (<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>The attachment and invasion of host cells is the key step in the <italic>P. aeruginosa</italic> infection cycle, and macrophages employ a variety of defense mechanisms to defend against invading pathogens. Phagocytosis and intracellular killing are two of the most important steps for bacterial eradication (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). The motility of <italic>P. aeruginosa</italic> regulated by the QS system was crucial for colonization (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B47">47</xref>). Studies showed that paeonol could resist the adhesion and invasion of <italic>P. aeruginosa</italic> to infect macrophages, which may be related to the fact that paeonol reduced the motility ability of <italic>P. aeruginosa</italic>. Previous studies had shown that <italic>P. aeruginosa</italic> could directly induce cell death to aggravate tissue damage through its QS system or toxic factors such as pyocyanin (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>). TEM results showed that PAO1 co-polymerized with each other to adhere to cell junctions and invaded the interior of cells. Compared with the PAO1 group, the phagocytosis ability of macrophages was enhanced in the paeonol treatment groups. Paeonol resists the cell toxicity induced by <italic>P. aeruginosa</italic> and improves cell viability. This work confirmed the effect of paeonol against <italic>P. aeruginosa</italic> by attenuating virulence factors and its cytoprotective activity during bacterial infection either by downregulating the virulence or providing a protective effect to the host cells. Zhang et&#xa0;al. have reported that phagocytic macrophages undergo apoptosis 48&#xa0;h after ingestion of <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="B50">50</xref>). Moussouni et&#xa0;al. have reported that OprF regulates <italic>P. aeruginosa</italic> virulence factors and protects macrophages during acute infection by avoiding phagolysosome destruction (<xref ref-type="bibr" rid="B51">51</xref>).</p>
<p>It has been reported that <italic>P. aeruginosa</italic> infection often exacerbates symptoms in patients, leading to organ dysfunction, followed by systemic inflammatory response syndrome and increased morbidity and mortality (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>). As an indispensable part of innate immunity, macrophages play an important role in inflammatory and immune responses. In this study, paeonol treatment significantly reduced <italic>P. aeruginosa</italic>-induced proinflammatory cytokine and improved anti-inflammatory factors produced by macrophages. The anti-inflammatory effect of paeonol was demonstrated in a PAO1-infected macrophage model and a PAO1 infected pneumonia model, and the results were consistent with LPS-induced RAW264.7 inflammatory factors (<xref ref-type="bibr" rid="B30">30</xref>). Generally, activated macrophages differentiate into M1 or M2 phenotypes. M1 macrophages (the classically activated, proinflammatory) increase the level of oxidative stress-induced products, and tissue damage was noted in the acute inflammatory phase, and M2 macrophages (the alternative activated, anti-inflammatory) decrease inflammation and promote tissue repair (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>). Classically activated (M1) macrophages can be triggered by recognizing Gram-negative bacteria, and cascade inflammatory responses will be triggered. TLR4 recruits myeloid MyD88, leading to proinflammatory cytokine production with activation of NF-&#x3ba;B and the downstream gene targets (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). The expression of key genes in the TLR4/MyD88/NF-&#x3ba;B signaling pathway and proinflammatory cytokines were induced by <italic>P. aeruginosa</italic> infection. Atter treatment with paeonol, the activation of inflammation pathway, expression of proinflammatory cytokines, and the M1 macrophages polarization were significantly inhibited in our results. Paeonol against PAO1 infection by inhibiting bacterial virulence and enhancing the clearance of pathogen by immune cells, which avoided severe inflammatory damage to cells and body. Collectively, this suggests that paeonol may represent a new promising anti-QS and anti-inflammatory agent that may prevent <italic>P. aeruginosa</italic>-mediated impairment of inflammation and infection.</p>
</sec>
<sec id="s5">
<title>Conclusion</title>
<p>This research exhibited direct evidence that paeonol possessed the anti-QS activity against <italic>P. aeruginosa</italic> virulence, which decreased the adhesion, invasion, and cytotoxicity of <italic>P. aeruginosa</italic> to macrophages. Paeonol improved cell viability in the cell model of macrophages infected with <italic>P. aeruginosa</italic> by inhibiting the expression of QS-related virulence genes of <italic>P. aeruginosa</italic> and reducing the activation of macrophage proinflammation cytokines and inflammation pathway. Paeonol also decreased the bacterial load and alleviated the inflammation response in a <italic>P. aeruginosa</italic> pneumonia model.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Sichuan Agricultural University.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author Contributions</title>
<p>HT and DY designed and performed the study, analyzed the data, and wrote the draft paper. LZhu, FS, GY, RG, HD, and LZhao performed experiments, analyzed the data, and edited the manuscript. ZW and YL designed, organized, supervised research, and edited the paper. All authors contributed to the paper and approved the submitted version.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by the International Science and Technology Cooperation Program of Sichuan: 2020YFH0143.</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoumot</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Respiratory Infection in Noncystic Fibrosis Bronchiectasis</article-title>. <source>Curr Opin Infect Dis</source> (<year>2010</year>) <volume>23</volume>(<issue>2</issue>):<page-range>165&#x2013;70</page-range>. doi: <pub-id pub-id-type="doi">10.1097/QCO.0b013e328335af91</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname> <given-names>TF</given-names>
</name>
</person-group>. <article-title>Pseudomonas Aeruginosa in Adults With Chronic Obstructive Pulmonary Disease</article-title>. <source>Curr Opin Pulm Med</source> (<year>2009</year>) <volume>15</volume>(<issue>2</issue>):<page-range>138&#x2013;42</page-range>. doi: <pub-id pub-id-type="doi">10.1097/MCP.0b013e328321861a</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilliam</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Lamont</surname> <given-names>IL</given-names>
</name>
<name>
<surname>Bilton</surname> <given-names>D</given-names>
</name>
<name>
<surname>Haworth</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Foweraker</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Pseudomonas Aeruginosa Adaptation and Diversification in the non-Cystic Fibrosis Bronchiectasis Lung</article-title>. <source>Eur Respir J</source> (<year>2017</year>) <volume>49</volume>(<issue>4</issue>). doi: <pub-id pub-id-type="doi">10.1183/13993003.02108-2016</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moradali</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Ghods</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rehm</surname> <given-names>BH</given-names>
</name>
</person-group>. <article-title>Pseudomonas Aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2017</year>) <volume>7</volume>:<elocation-id>39</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2017.00039</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname> <given-names>CI</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HB</given-names>
</name>
<name>
<surname>Park</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Choe</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>MD</given-names>
</name>
<etal/>
</person-group>. <article-title>Pseudomonas Aeruginosa Bacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome</article-title>. <source>Clin Infect Dis</source> (<year>2003</year>) <volume>37</volume>(<issue>6</issue>):<page-range>745&#x2013;51</page-range>. doi: <pub-id pub-id-type="doi">10.1086/377200</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Schaefer</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Parsek</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Moninger</surname> <given-names>TO</given-names>
</name>
<name>
<surname>Welsh</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Greenberg</surname> <given-names>EP</given-names>
</name>
</person-group>. <article-title>Quorum-Sensing Signals Indicate That Cystic Fibrosis Lungs Are Infected With Bacterial Biofilms</article-title>. <source>Nature</source> (<year>2000</year>) <volume>407</volume>(<issue>6805</issue>):<page-range>762&#x2013;4</page-range>. doi: <pub-id pub-id-type="doi">10.1038/35037627</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassler</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Losick</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Bacterially Speaking</article-title>. <source>Cell</source> (<year>2006</year>) <volume>125</volume>(<issue>2</issue>):<page-range>237&#x2013;46</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2006.04.001</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swift</surname> <given-names>S</given-names>
</name>
<name>
<surname>Throup</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>P</given-names>
</name>
<name>
<surname>Salmond</surname> <given-names>GP</given-names>
</name>
<name>
<surname>Stewart</surname> <given-names>GS</given-names>
</name>
</person-group>. <article-title>Quorum Sensing: A Population-Density Component in the Determination of Bacterial Phenotype</article-title>. <source>Trends Biochem Sci</source> (<year>1996</year>) <volume>21</volume>(<issue>6</issue>):<page-range>214&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0968-0004(96)80018-1</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Lory</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Analysis of Regulatory Networks in Pseudomonas Aeruginosa by Genomewide Transcriptional Profiling</article-title>. <source>Curr Opin Microbiol</source> (<year>2004</year>) <volume>7</volume>(<issue>1</issue>):<fpage>39</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2003.12.009</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geisenberger</surname> <given-names>O</given-names>
</name>
<name>
<surname>Givskov</surname> <given-names>M</given-names>
</name>
<name>
<surname>Riedel</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hoiby</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tummler</surname> <given-names>B</given-names>
</name>
<name>
<surname>Eberl</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Production of N-Acyl-L-Homoserine Lactones by P. Aeruginosa Isolates From Chronic Lung Infections Associated With Cystic Fibrosis</article-title>. <source>FEMS Microbiol Lett</source> (<year>2000</year>) <volume>184</volume>(<issue>2</issue>):<page-range>273&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0378-1097(00)00059-8</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adonizio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mathee</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Inhibition of Quorum Sensing-Controlled Virulence Factor Production in Pseudomonas Aeruginosa by South Florida Plant Extracts</article-title>. <source>Antimicrobial Agents chemother</source> (<year>2008</year>) <volume>52</volume>(<issue>1</issue>):<fpage>198</fpage>&#x2013;<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00612-07</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stehling</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Silveira</surname> <given-names>WD</given-names>
</name>
<name>
<surname>Leite</surname> <given-names>DS</given-names>
</name>
</person-group>. <article-title>Study of Biological Characteristics of Pseudomonas Aeruginosa Strains Isolated From Patients With Cystic Fibrosis and From Patients With Extra-Pulmonary Infections</article-title>. <source>Braz J Infect Dis</source> (<year>2008</year>) <volume>12</volume>(<issue>1</issue>):<page-range>86&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1590/S1413-86702008000100018</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'May</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tufenkji</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>The Swarming Motility of Pseudomonas Aeruginosa Is Blocked by Cranberry Proanthocyanidins and Other Tannin-Containing Materials</article-title>. <source>Appl Environ Microbiol</source> (<year>2011</year>) <volume>77</volume>(<issue>9</issue>):<page-range>3061&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1128/AEM.02677-10</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieuwenhuis</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Matsumoto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Exley</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schleipman</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Glickman</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bailey</surname> <given-names>DT</given-names>
</name>
<etal/>
</person-group>. <article-title>CD1d-Dependent Macrophage-Mediated Clearance of Pseudomonas Aeruginosa From Lung</article-title>. <source>Nat Med</source> (<year>2002</year>) <volume>8</volume>(<issue>6</issue>):<page-range>588&#x2013;93</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nm0602-588</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Prince</surname> <given-names>AS</given-names>
</name>
</person-group>. <article-title>Activation of Inflammasome Signaling Mediates Pathology of Acute P. Aeruginosa Pneumonia</article-title>. <source>J Clin Invest</source> (<year>2013</year>) <volume>123</volume>(<issue>4</issue>):<page-range>1630&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI66142</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>CC</given-names>
</name>
</person-group>. <article-title>Inflammatory Response of Macrophages in Infection</article-title>. <source>Hepatobiliary Pancreat Dis Int</source> (<year>2014</year>) <volume>13</volume>(<issue>2</issue>):<page-range>138&#x2013;52</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1499-3872(14)60024-2</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pollard</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Currie</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rosenberger</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Heale</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Finlay</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Speert</surname> <given-names>DP</given-names>
</name>
</person-group>. <article-title>Differential Post-Transcriptional Activation of Human Phagocytes by Different Pseudomonas Aeruginosa Isolates</article-title>. <source>Cell Microbiol</source> (<year>2004</year>) <volume>6</volume>(<issue>7</issue>):<page-range>639&#x2013;50</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1462-5822.2004.00388.x</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romagne</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Current and Future Drugs Targeting One Class of Innate Immunity Receptors: The Toll-Like Receptors</article-title>. <source>Drug Discovery Today</source> (<year>2007</year>) <volume>12</volume>(<issue>1-2</issue>):<page-range>80&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.drudis.2006.11.007</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawai</surname> <given-names>T</given-names>
</name>
<name>
<surname>Akira</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>The Role of Pattern-Recognition Receptors in Innate Immunity: Update on Toll-Like Receptors</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>(<issue>5</issue>):<page-range>373&#x2013;84</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.1863</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenberg</surname> <given-names>S</given-names>
</name>
<name>
<surname>Grinstein</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Phagocytosis and Innate Immunity</article-title>. <source>Curr Opin Immunol</source> (<year>2002</year>) <volume>14</volume>(<issue>1</issue>):<page-range>136&#x2013;45</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0952-7915(01)00309-0</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Epelman</surname> <given-names>S</given-names>
</name>
<name>
<surname>Stack</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bell</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>E</given-names>
</name>
<name>
<surname>Neely</surname> <given-names>GG</given-names>
</name>
<name>
<surname>Krutzik</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Different Domains of Pseudomonas Aeruginosa Exoenzyme S Activate Distinct TLRs</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>(<issue>3</issue>):<page-range>2031&#x2013;40</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.173.3.2031</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trinchieri</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sher</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Cooperation of Toll-Like Receptor Signals in Innate Immune Defence</article-title>. <source>Nat Rev Immunol</source> (<year>2007</year>) <volume>7</volume>(<issue>3</issue>):<page-range>179&#x2013;90</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri2038</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>G</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>EGCG-Mediated Potential Inhibition of Biofilm Development and Quorum Sensing in Pseudomonas Aeruginosa</article-title>. <source>Int J Mol Sci</source> (<year>2021</year>) <volume>22</volume>(<issue>9</issue>). doi: <pub-id pub-id-type="doi">10.3390/ijms22094946</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudrappa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bais</surname> <given-names>HP</given-names>
</name>
</person-group>. <article-title>Curcumin, a Known Phenolic From Curcuma Longa, Attenuates the Virulence of Pseudomonas Aeruginosa PAO1 in Whole Plant and Animal Pathogenicity Models</article-title>. <source>J Agric Food Chem</source> (<year>2008</year>) <volume>56</volume>(<issue>6</issue>):<page-range>1955&#x2013;62</page-range>. doi: <pub-id pub-id-type="doi">10.1021/jf072591j</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antunes</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Tavares</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Teixeira</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Teixeira</surname> <given-names>MO</given-names>
</name>
<name>
<surname>Homem</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Amorim</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Eugenol-Containing Essential Oils Loaded Onto Chitosan/Polyvinyl Alcohol Blended Films and Their Ability to Eradicate Staphylococcus Aureus or Pseudomonas Aeruginosa From Infected Microenvironments</article-title>. <source>Pharmaceutics</source> (<year>2021</year>) <volume>13</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.3390/pharmaceutics13020195</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>FN</given-names>
</name>
<name>
<surname>Teng</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>YC</given-names>
</name>
</person-group>. <article-title>Aggregation Inhibitory Activity of Minor Acetophenones From Paeonia Species</article-title>. <source>Planta Med</source> (<year>1999</year>) <volume>65</volume>(<issue>7</issue>):<page-range>595&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1055/s-1999-14030</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>LF</given-names>
</name>
</person-group>. <article-title>Paeonol: Pharmacological Effects and Mechanisms of Action</article-title>. <source>Int Immunopharmacol</source> (<year>2019</year>) <volume>72</volume>:<page-range>413&#x2013;21</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2019.04.033</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Paeonol Attenuates Quorum-Sensing Regulated Virulence and Biofilm Formation in Pseudomonas Aeruginosa</article-title>. <source>Front Microbiol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>692474</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.692474</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HH</given-names>
</name>
</person-group>. <article-title>A Genome-Wide Microarray Analysis Reveals Anti-Inflammatory Target Genes of Paeonol in Macrophages</article-title>. <source>Inflammation Res</source> (<year>2008</year>) <volume>57</volume>(<issue>4</issue>):<page-range>189&#x2013;98</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00011-007-7190-3</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>P</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Paeonol Attenuates Inflammation by Confining HMGB1 to the Nucleus</article-title>. <source>J Cell Mol Med</source> (<year>2021</year>) <volume>25</volume>(<issue>6</issue>):<page-range>2885&#x2013;99</page-range>. doi: <pub-id pub-id-type="doi">10.1111/jcmm.16319</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thurlow</surname> <given-names>LR</given-names>
</name>
<name>
<surname>Hanke</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Fritz</surname> <given-names>T</given-names>
</name>
<name>
<surname>Angle</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aldrich</surname> <given-names>A</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>Staphylococcus Aureus Biofilms Prevent Macrophage Phagocytosis and Attenuate Inflammation In Vivo</article-title>. <source>J Immunol (Baltimore Md: 1950)</source> (<year>2011</year>) <volume>186</volume>(<issue>11</issue>):<page-range>6585&#x2013;96</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1002794</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traber</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Dimbo</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Symer</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Korkmaz</surname> <given-names>FT</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Mizgerd</surname> <given-names>JP</given-names>
</name>
<etal/>
</person-group>. <article-title>Roles of Interleukin-11 During Acute Bacterial Pneumonia</article-title>. <source>PloS One</source> (<year>2019</year>) <volume>14</volume>(<issue>8</issue>):<elocation-id>e221029</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0221029</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname> <given-names>J</given-names>
</name>
<name>
<surname>Davies</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Origins and Evolution of Antibiotic Resistance</article-title>. <source>Microbiol Mol Biol Rev</source> (<year>2010</year>) <volume>74</volume>(<issue>3</issue>):<page-range>417&#x2013;33</page-range>. doi: <pub-id pub-id-type="doi">10.1128/MMBR.00016-10</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levin</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Barone</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Penco</surname> <given-names>J</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Marinho</surname> <given-names>IS</given-names>
</name>
<name>
<surname>Arruda</surname> <given-names>EA</given-names>
</name>
<etal/>
</person-group>. <article-title>Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug-Resistant Pseudomonas Aeruginosa and Acinetobacter Baumannii</article-title>. <source>Clin Infect Dis</source> (<year>1999</year>) <volume>28</volume>(<issue>5</issue>):<page-range>1008&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1086/514732</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Perdreau-Remington</surname> <given-names>F</given-names>
</name>
<name>
<surname>Rieg</surname> <given-names>G</given-names>
</name>
<name>
<surname>Mehdi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Perlroth</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bayer</surname> <given-names>AS</given-names>
</name>
<etal/>
</person-group>. <article-title>Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus in Los Angeles</article-title>. <source>N Engl J Med</source> (<year>2005</year>) <volume>352</volume>(<issue>14</issue>):<page-range>1445&#x2013;53</page-range>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa042683</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadikot</surname> <given-names>RT</given-names>
</name>
<name>
<surname>Blackwell</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Christman</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Prince</surname> <given-names>AS</given-names>
</name>
</person-group>. <article-title>Pathogen-Host Interactions in Pseudomonas Aeruginosa Pneumonia</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2005</year>) <volume>171</volume>(<issue>11</issue>):<page-range>1209&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1164/rccm.200408-1044SO</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mesaros</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nordmann</surname> <given-names>P</given-names>
</name>
<name>
<surname>Pl&#xe9;siat</surname> <given-names>P</given-names>
</name>
<name>
<surname>Roussel-Delvallez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Van Eldere</surname> <given-names>J</given-names>
</name>
<name>
<surname>Glupczynski</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Pseudomonas Aeruginosa: Resistance and Therapeutic Options at the Turn of the New Millennium</article-title>. <source>Clin Microbiol Infect</source> (<year>2007</year>) <volume>13</volume>(<issue>6</issue>):<page-range>560&#x2013;78</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01681.x</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwasaki</surname> <given-names>A</given-names>
</name>
<name>
<surname>Medzhitov</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Control of Adaptive Immunity by the Innate Immune System</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>(<issue>4</issue>):<page-range>343&#x2013;53</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3123</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aachoui</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sagulenko</surname> <given-names>V</given-names>
</name>
<name>
<surname>Miao</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Stacey</surname> <given-names>KJ</given-names>
</name>
</person-group>. <article-title>Inflammasome-Mediated Pyroptotic and Apoptotic Cell Death, and Defense Against Infection</article-title>. <source>Curr Opin Microbiol</source> (<year>2013</year>) <volume>16</volume>(<issue>3</issue>):<page-range>319&#x2013;26</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2013.04.004</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fleiszig</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Zaidi</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Fletcher</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Preston</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Pier</surname> <given-names>GB</given-names>
</name>
</person-group>. <article-title>Pseudomonas Aeruginosa Invades Corneal Epithelial Cells During Experimental Infection</article-title>. <source>Infect Immun</source> (<year>1994</year>) <volume>62</volume>(<issue>8</issue>):<page-range>3485&#x2013;93</page-range>. doi: <pub-id pub-id-type="doi">10.1128/iai.62.8.3485-3493.1994</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Del Mar Cendra</surname> <given-names>M</given-names>
</name>
<name>
<surname>Torrents</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Differential Adaptability Between Reference Strains and Clinical Isolates of Pseudomonas Aeruginosa Into the Lung Epithelium Intracellular Lifestyle</article-title>. <source>Virulence</source> (<year>2020</year>) <volume>11</volume>(<issue>1</issue>):<page-range>862&#x2013;76</page-range>. doi: <pub-id pub-id-type="doi">10.1080/21505594.2020.1787034</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Parsek</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Pearson</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Iglewski</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Costerton</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Greenberg</surname> <given-names>EP</given-names>
</name>
</person-group>. <article-title>The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm</article-title>. <source>Science</source> (<year>1998</year>) <volume>280</volume>(<issue>5361</issue>):<page-range>295&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.280.5361.295</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kharazmi</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Interactions of Pseudomonas Aeruginosa Proteases With the Cells of the Immune System</article-title>. <source>Antibiot Chemother</source> (<year>1971</year>) <volume>42</volume>:<page-range>42&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1159/000417602</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santajit</surname> <given-names>S</given-names>
</name>
<name>
<surname>Seesuay</surname> <given-names>W</given-names>
</name>
<name>
<surname>Mahasongkram</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sookrung</surname> <given-names>N</given-names>
</name>
<name>
<surname>Pumirat</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ampawong</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Human Single-Chain Variable Fragments Neutralize Pseudomonas Aeruginosa Quorum Sensing Molecule, 3o-C12-HSL, and Prevent Cells From the HSL-Mediated Apoptosis</article-title>. <source>Front Microbiol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>1172</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.01172</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nie</surname> <given-names>X</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Hazlett</surname> <given-names>LD</given-names>
</name>
<etal/>
</person-group>. <article-title>TREM-2 Promotes Host Resistance Against Pseudomonas Aeruginosa Infection by Suppressing Corneal Inflammation <italic>via</italic> a PI3K/Akt Signaling Pathway</article-title>. <source>Invest Ophthalmol Visual Sci</source> (<year>2013</year>) <volume>54</volume>(<issue>5</issue>):<page-range>3451&#x2013;62</page-range>. doi: <pub-id pub-id-type="doi">10.1167/iovs.12-10938</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Minhaowu</surname> <given-names>&#xa0;</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb</article-title>. <source>PloS Pathog</source> (<year>2013</year>) <volume>9</volume>(<issue>10</issue>):<elocation-id>e1003697</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1003697</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deligianni</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pattison</surname> <given-names>S</given-names>
</name>
<name>
<surname>Berrar</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ternan</surname> <given-names>NG</given-names>
</name>
<name>
<surname>Haylock</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>JE</given-names>
</name>
<etal/>
</person-group>. <article-title>Pseudomonas Aeruginosa Cystic Fibrosis Isolates of Similar RAPD Genotype Exhibit Diversity in Biofilm Forming Ability In Vitro</article-title>. <source>BMC Microbiol</source> (<year>2010</year>) <volume>10</volume>:<fpage>38</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2180-10-38</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rada</surname> <given-names>B</given-names>
</name>
<name>
<surname>Leto</surname> <given-names>TL</given-names>
</name>
</person-group>. <article-title>Pyocyanin Effects on Respiratory Epithelium: Relevance in Pseudomonas Aeruginosa Airway Infections</article-title>. <source>Trends Microbiol</source> (<year>2013</year>) <volume>21</volume>(<issue>2</issue>):<fpage>73</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tim.2012.10.004</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harshey</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Bacterial Motility on a Surface: Many Ways to a Common Goal</article-title>. <source>Annu Rev Microbiol</source> (<year>2003</year>) <volume>57</volume>:<page-range>249&#x2013;73</page-range>. doi: <pub-id pub-id-type="doi">10.1146/annurev.micro.57.030502.091014</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Apoptosis are Induced in J774 Macrophages Upon Phagocytosis and Killing of Pseudomonas Aeruginosa</article-title>. <source>Cell Immunol</source> (<year>2013</year>) <volume>286</volume>(<issue>1-2</issue>):<page-range>11&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cellimm.2013.10.006</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moussouni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Berry</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sipka</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Pseudomonas Aeruginosa OprF Plays a Role in Resistance to Macrophage Clearance During Acute Infection</article-title>. <source>Sci Rep</source> (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>359</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-79678-0</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname> <given-names>D</given-names>
</name>
<name>
<surname>Khair</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Honeybourne</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Impact of Sputum Bacteria on Airway Inflammation and Health Status in Clinical Stable COPD</article-title>. <source>Eur Respir J</source> (<year>2004</year>) <volume>23</volume>(<issue>5</issue>):<page-range>685&#x2013;91</page-range>. doi: <pub-id pub-id-type="doi">10.1183/09031936.04.00056804</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hauser</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bar-Meir</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis</article-title>. <source>Clin Microbiol Rev</source> (<year>2011</year>) <volume>24</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00036-10</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sica</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mantovani</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Macrophage Plasticity and Polarization: <italic>In Vivo</italic> Veritas</article-title>. <source>J Clin Invest</source> (<year>2012</year>) <volume>122</volume>(<issue>3</issue>):<page-range>787&#x2013;95</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI59643</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mantovani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Biswas</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Galdiero</surname> <given-names>MR</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage Plasticity and Polarization in Tissue Repair and Remodelling</article-title>. <source>J Pathol</source> (<year>2013</year>) <volume>229</volume>(<issue>2</issue>):<page-range>176&#x2013;85</page-range>. doi: <pub-id pub-id-type="doi">10.1002/path.4133</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anwar</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Basith</surname> <given-names>S</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Negative Regulatory Approaches to the Attenuation of Toll-Like Receptor Signaling</article-title>. <source>Exp Mol Med</source> (<year>2013</year>) <volume>45</volume>:<elocation-id>e11</elocation-id>. doi: <pub-id pub-id-type="doi">10.1038/emm.2013.28</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>G</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Polydatin Reduces Staphylococcus Aureus Lipoteichoic Acid-Induced Injury by Attenuating Reactive Oxygen Species Generation and TLR2-NFkappaB Signalling</article-title>. <source>J Cell Mol Med</source> (<year>2017</year>) <volume>21</volume>(<issue>11</issue>):<page-range>2796&#x2013;808</page-range>. doi: <pub-id pub-id-type="doi">10.1111/jcmm.13194</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>